| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.05. | Altamira Therapeutics Ltd: Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation | 11 | GlobeNewswire (Europe) | Hamilton, Bermuda, May 01, 2024 (GLOBE NEWSWIRE) -- Continued expansion of IP portfolio related to RNA delivery Treatment of rheumatoid arthritis as one of the key therapeutic indications HAMILTON... ► Artikel lesen | |
| 24.04. | ALTAMIR: Altamir's General Meeting of 23 April 2024 | 216 | Actusnews Wire | Altamir's General Meeting of 23 April 2024
Paris, 24 April 2024 - Altamir's ordinary general meeting of shareholders took place on 23 April 2024. Those taking part held 77.86% of the company's... ► Artikel lesen | |
| 24.04. | Altamira reports publication of positive results from NASAR clinical trial with Bentrio | 1 | Seeking Alpha | ||
| 24.04. | Altamira Therapeutics Ltd: Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal | 74 | GlobeNewswire (Europe) | Hamilton, Bermuda, April 24, 2024 (GLOBE NEWSWIRE) -- Detailed results from randomized controlled Bentrio® trial in seasonal allergic rhinitis published in Allergy journal Study met primary efficacy... ► Artikel lesen | |
| 17.04. | Altamira Gold Corp.: Altamira Gold Reports First Drill Results from Follow-up Drilling at Intrusive-hosted Maria Bonita Gold Discovery, Cajueiro Project, Brazil | 355 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - April 17, 2024) - Altamira Gold Corp. (TSXV: ALTA) (FSE: T6UP) (OTC Pink: EQTRF) ("Altamira" or the "Company") is pleased to announce the results of the... ► Artikel lesen | |
| 12.04. | Altamira Therapeutics Ltd. (CYTO) Q4 2023 Earnings Call Transcript | 3 | Insider Monkey | ||
| 11.04. | Earnings call: Altamira Therapeutics reports strategic progress in 2023 | 2 | Investing.com | ||
| 10.04. | Altamira Therapeutics Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 10.04. | Altamira Therapeutics Ltd. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 10.04. | Altamira Therapeutics Ltd. - F-1, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 10.04. | Altamira Therapeutics GAAP EPS of -CHF14.80 | 1 | Seeking Alpha | ||
| 10.04. | Altamira Therapeutics Ltd. - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings | ||
| 04.04. | Altamira Therapeutics Ltd: Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024 | 1 | GlobeNewswire (USA) | ||
| 03.04. | ALTAMIR: Altamir's 2023 Universal Registration Document is available | 193 | Actusnews Wire | Paris, 3 April 2024 - Altamir's 2023 Registration Document was filed with the French Financial Markets Authority (AMF) on 3 April 2024.
The following documents are included in the Registration... ► Artikel lesen | |
| 03.04. | ALTAMIR: Information relating to the Shareholders' Meeting of April 23rd, 2024 | 234 | Actusnews Wire | Paris, 3 April 2024 - The Company's shareholders are invited to participate in the Annual General Meeting (AGM), which will be held on Tuesday 23 April 2024, at 10:00 am, at the Salons des Arts... ► Artikel lesen | |
| 25.03. | Altamira stock rallies 44% on Univercells mRNA collaboration | 1 | Seeking Alpha | ||
| 25.03. | Why Altamira Therapeutics Stock Is Racing Higher | 3 | Benzinga.com | ||
| 25.03. | Altamira, Univercells Partner on Nanoparticle-Delivered mRNA Vaccines | 1 | Contract Pharma | ||
| 25.03. | Altamira and Univercells partner to test mRNA vaccine delivery | 1 | Investing.com | ||
| 25.03. | Altamira Therapeutics Ltd: Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines | 482 | GlobeNewswire (Europe) | HAMILTON, BERMUDA, March 25, 2024 (GLOBE NEWSWIRE) -- Univercells to test proprietary mRNA vaccine delivered with Altamira's SemaPhore nanoparticlesTargeting safer and accessible mRNA vaccines ... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 3.296 |
| NEL | 3.099 |
| PALANTIR TECHNOLOGIES | 3.025 |
| TUI | 2.193 |
| INFINEON | 2.117 |
| BAYER | 2.007 |
| SIEMENS ENERGY | 1.761 |
| DEUTSCHE BANK | 1.742 |
| DEUTSCHE LUFTHANSA | 1.630 |
| NVIDIA | 1.576 |
| MERCEDES-BENZ | 1.538 |
| BYD | 1.419 |
| VARTA | 1.378 |
| RHEINMETALL | 1.234 |
| ALLIANZ | 1.204 |
| AIXTRON SE | 1.149 |
| RENK GROUP | 1.124 |
| COMMERZBANK | 1.081 |
| RWE | 1.074 |
| PLUG POWER | 1.067 |
| TESLA | 1.058 |
| SUPER MICRO COMPUTER | 1.055 |
| VOLKSWAGEN | 1.046 |
| BASF | 964 |
| TEAMVIEWER | 955 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
